Year

2012

Status

Exited

 

Team

Field

Peptide technology

Location

Groningen (The Netherlands)

Fund

BGV I

Lanthio

Lanthio Pharma discovers and develops Lanthiopeptides, a new class of peptides with high target selectivity and improved “drug-like” properties. Lanthio pharma was acquired by Morphosys in 2015.